Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...

After more than two decades on the Delaware waterfront, it’s being prepped in Mobile, Ala., for its final (assisted) cruise and new life as the world’s largest artificial reef ...

Survivor benefits are currently paid to around 5.8 million Americans nationwide, with nearly 4 million of those being ...

It comes as Americans of all ages continue to navigate rising costs. In October, the Social Security Administration (SSA) ...

Although some outcomes showed small to medium effect sizes, these results must be interpreted cautiously given the presence ...

Wall Street continued its upward rally on Tuesday as all three major averages closed in the green and the Dow rose by more than 700 points.

Looking at the current players in the Cleveland Guardians organization, here's what a possible lineup could look like during ...

Social Security's looming shortfall is often framed as a distant problem for retirees, but the math behind the program is ...

Objectives Understanding contextual drivers of family planning is crucial for designing effective, context-specific policies and programmes. This study aimed to assess (1) the extent to which province ...

South Korea’s growing investment in American shipbuilding could foster the development of ships capable of using next ...